Sath Shukla

CEO and President at Spero Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2023

3 years of board service in total across 1 board, counting each seat separately. Longest: Spero Therapeutics Inc., 3 years.

Spero Therapeutics Inc. Director · CEO and President
3 years · Since 2023

Chief executive roles

Spero Therapeutics Inc. · CEO and President
Dates unknown

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Feb 5, 2025 Spero Therapeutics Inc. Open-market sale −6,139 $0.78 $4,788
Feb 5, 2025 Spero Therapeutics Inc. Open-market sale −42,786 $0.78 $33,373
Feb 5, 2025 Spero Therapeutics Inc. Open-market sale −106,408 $0.78 $82,998
Feb 3, 2025 Spero Therapeutics Inc. Grant or award +751,407 — —
Aug 27, 2024 Spero Therapeutics Inc. Open-market sale −2,757 $1.35 $3,722
Aug 5, 2024 Spero Therapeutics Inc. Open-market sale −17,641 $1.31 $23,110
Aug 2, 2024 Spero Therapeutics Inc. Open-market sale −14,800 $1.32 $19,536
Feb 5, 2024 Spero Therapeutics Inc. Open-market sale −45,093 $1.45 $65,385
Feb 2, 2024 Spero Therapeutics Inc. Open-market sale −30,901 $1.37 $42,334
Feb 1, 2024 Spero Therapeutics Inc. Grant or award +679,501 — —
Aug 29, 2023 Spero Therapeutics Inc. Open-market sale −4,163 $1.30 $5,412
Aug 28, 2023 Spero Therapeutics Inc. Open-market sale −1,854 $1.26 $2,336
Aug 1, 2023 Spero Therapeutics Inc. Grant or award +266,000 — —

Questions about Sath Shukla

What boards is Sath Shukla on?

Sath Shukla sits on the board of Spero Therapeutics Inc.

What company is Sath Shukla the CEO of?

Sath Shukla is CEO and President of Spero Therapeutics Inc.

How long has Sath Shukla served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.